These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 18780965)

  • 1. Limited Alzheimer-type neurodegeneration in experimental obesity and type 2 diabetes mellitus.
    Moroz N; Tong M; Longato L; Xu H; de la Monte SM
    J Alzheimers Dis; 2008 Sep; 15(1):29-44. PubMed ID: 18780965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer's disease: link to brain reductions in acetylcholine.
    Rivera EJ; Goldin A; Fulmer N; Tavares R; Wands JR; de la Monte SM
    J Alzheimers Dis; 2005 Dec; 8(3):247-68. PubMed ID: 16340083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central insulin and insulin-like growth factor-1 signaling: implications for diabetes associated dementia.
    Zemva J; Schubert M
    Curr Diabetes Rev; 2011 Sep; 7(5):356-66. PubMed ID: 21916834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of diet- and genetically-induced brain insulin resistance on amyloid pathology in a mouse model of Alzheimer's disease.
    Wakabayashi T; Yamaguchi K; Matsui K; Sano T; Kubota T; Hashimoto T; Mano A; Yamada K; Matsuo Y; Kubota N; Kadowaki T; Iwatsubo T
    Mol Neurodegener; 2019 Apr; 14(1):15. PubMed ID: 30975165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of nitrosamine-mediated neurodegeneration: potential relevance to sporadic Alzheimer's disease.
    de la Monte SM; Tong M
    J Alzheimers Dis; 2009; 17(4):817-25. PubMed ID: 19542621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic ceramide may mediate brain insulin resistance and neurodegeneration in type 2 diabetes and non-alcoholic steatohepatitis.
    Lyn-Cook LE; Lawton M; Tong M; Silbermann E; Longato L; Jiao P; Mark P; Wands JR; Xu H; de la Monte SM
    J Alzheimers Dis; 2009; 16(4):715-29. PubMed ID: 19387108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease--is this type 3 diabetes?
    Steen E; Terry BM; Rivera EJ; Cannon JL; Neely TR; Tavares R; Xu XJ; Wands JR; de la Monte SM
    J Alzheimers Dis; 2005 Feb; 7(1):63-80. PubMed ID: 15750215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential involvement of insulin receptor substrate (IRS)-1 and IRS-2 in brain insulin signaling is associated with the effects on amyloid pathology in a mouse model of Alzheimer's disease.
    Ochiai T; Sano T; Nagayama T; Kubota N; Kadowaki T; Wakabayashi T; Iwatsubo T
    Neurobiol Dis; 2021 Nov; 159():105510. PubMed ID: 34537327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitrosamine exposure causes insulin resistance diseases: relevance to type 2 diabetes mellitus, non-alcoholic steatohepatitis, and Alzheimer's disease.
    Tong M; Neusner A; Longato L; Lawton M; Wands JR; de la Monte SM
    J Alzheimers Dis; 2009; 17(4):827-44. PubMed ID: 20387270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic Stress Alters Antioxidant Systems, Suppresses the Adiponectin Receptor 1 and Induces Alzheimer's Like Pathology in Mice Brain.
    Hahm JR; Jo MH; Ullah R; Kim MW; Kim MO
    Cells; 2020 Jan; 9(1):. PubMed ID: 31963819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased food intake leads to obesity and insulin resistance in the tg2576 Alzheimer's disease mouse model.
    Kohjima M; Sun Y; Chan L
    Endocrinology; 2010 Apr; 151(4):1532-40. PubMed ID: 20176720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracerebral streptozotocin model of type 3 diabetes: relevance to sporadic Alzheimer's disease.
    Lester-Coll N; Rivera EJ; Soscia SJ; Doiron K; Wands JR; de la Monte SM
    J Alzheimers Dis; 2006 Mar; 9(1):13-33. PubMed ID: 16627931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin Resistance as Common Molecular Denominator Linking Obesity to Alzheimer's Disease.
    Nuzzo D; Picone P; Baldassano S; Caruana L; Messina E; Marino Gammazza A; Cappello F; Mulè F; Di Carlo M
    Curr Alzheimer Res; 2015; 12(8):723-35. PubMed ID: 26159189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain Insulin Signaling Is Increased in Insulin-Resistant States and Decreases in FOXOs and PGC-1α and Increases in Aβ1-40/42 and Phospho-Tau May Abet Alzheimer Development.
    Sajan M; Hansen B; Ivey R; Sajan J; Ari C; Song S; Braun U; Leitges M; Farese-Higgs M; Farese RV
    Diabetes; 2016 Jul; 65(7):1892-903. PubMed ID: 26895791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Connective tissue growth factor (CTGF) expression in the brain is a downstream effector of insulin resistance- associated promotion of Alzheimer's disease beta-amyloid neuropathology.
    Zhao Z; Ho L; Wang J; Qin W; Festa ED; Mobbs C; Hof P; Rocher A; Masur S; Haroutunian V; Pasinetti GM
    FASEB J; 2005 Dec; 19(14):2081-2. PubMed ID: 16186174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral and Central Effects of Memantine in a Mixed Preclinical Mice Model of Obesity and Familial Alzheimer's Disease.
    Ettcheto M; Sánchez-López E; Gómez-Mínguez Y; Cabrera H; Busquets O; Beas-Zarate C; García ML; Carro E; Casadesus G; Auladell C; Vázquez Carrera M; Folch J; Camins A
    Mol Neurobiol; 2018 Sep; 55(9):7327-7339. PubMed ID: 29404958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long term high fat diet induces metabolic disorders and aggravates behavioral disorders and cognitive deficits in MAPT P301L transgenic mice.
    Xiong J; Deng I; Kelliny S; Lin L; Bobrovskaya L; Zhou XF
    Metab Brain Dis; 2022 Aug; 37(6):1941-1957. PubMed ID: 35704147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linagliptin, a DPP-4 inhibitor, ameliorates Aβ (1-42) peptides induced neurodegeneration and brain insulin resistance (BIR) via insulin receptor substrate-1 (IRS-1) in rat model of Alzheimer's disease.
    Siddiqui N; Ali J; Parvez S; Zameer S; Najmi AK; Akhtar M
    Neuropharmacology; 2021 Sep; 195():108662. PubMed ID: 34119519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic adiponectin deficiency leads to Alzheimer's disease-like cognitive impairments and pathologies through AMPK inactivation and cerebral insulin resistance in aged mice.
    Ng RC; Cheng OY; Jian M; Kwan JS; Ho PW; Cheng KK; Yeung PK; Zhou LL; Hoo RL; Chung SK; Xu A; Lam KS; Chan KH
    Mol Neurodegener; 2016 Nov; 11(1):71. PubMed ID: 27884163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contributions of brain insulin resistance and deficiency in amyloid-related neurodegeneration in Alzheimer's disease.
    de la Monte SM
    Drugs; 2012 Jan; 72(1):49-66. PubMed ID: 22191795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.